0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Cardiovascular medicine

Buy Now

Combination Therapy In Dyslipidemia (Hardcover, 2015 ed.) Loot Price: R3,284
Discovery Miles 32 840
You Save: R439 (12%)
Combination Therapy In Dyslipidemia (Hardcover, 2015 ed.): Maciej Banach

Combination Therapy In Dyslipidemia (Hardcover, 2015 ed.)

Maciej Banach

 (sign in to rate)
List price R3,723 Loot Price R3,284 Discovery Miles 32 840 | Repayment Terms: R308 pm x 12* You Save R439 (12%)

Bookmark and Share

Expected to ship within 12 - 17 working days

Comprising contributions from leading lipidologists from around the world, this book presents the latest and most comprehensive knowledge on the different options for combination therapy of dyslipidemia and includes discussion of future therapies that are currently in late stages of clinical evaluation. Dyslipidemia is a leading cause of cardiovascular morbidity and mortality and most patients with this condition fail to achieve adequate control of their serum lipid levels with monotherapy. However, recent US and European guideline recommendations, based on randomized, controlled trials, fail to discuss combination therapy options for patients with dyslipidemia. Statins remain the mainstay of drug therapy for hyperlipidemia and chapters in this book specifically examine the role of add-on therapy with different agents modulating the different lipid fractions in the blood, e.g. bile acid sequestrants, fibric acid derivatives (fibrates), omega-3 fatty acids (fish oils), inhibitors of Niemann-Pick C1 like 1 (NPC1L1) protein, cholesteryl ester transfer protein (CETP), apolipoprotein B-100 and microsomal triglyceride transfer protein (MTP) and the emerging proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. There is additional discussion of the role of non-drug therapy options such as nutraceuticals, functional foods and lipoprotein apheresis. The book also discusses the combination of antihypertensive drugs with lipid-lowering drugs in the management of cardiovascular risk in patents with dyslipidemia.

General

Imprint: Adis International
Country of origin: Switzerland
Release date: July 2015
First published: 2015
Editors: Maciej Banach
Dimensions: 235 x 155 x 14mm (L x W x T)
Format: Hardcover - Cloth over boards
Pages: 205
Edition: 2015 ed.
ISBN-13: 978-3-319-20432-1
Categories: Books > Medicine > Clinical & internal medicine > Cardiovascular medicine
Books > Medicine > Other branches of medicine > Pharmacology > General
LSN: 3-319-20432-7
Barcode: 9783319204321

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners